Organovo Holdings Inc. (NASDAQ: ONVO)
$0.3640
+0.0141 ( +1.11% ) 101.6K
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.
Market Data
Open
$0.3640
Previous close
$0.3499
Volume
101.6K
Market cap
$5.42M
Day range
$0.3530 - $0.3810
52 week range
$0.3154 - $1.7400
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 11 | Aug 09, 2024 |
| 4 | Insider transactions | 1 | Aug 07, 2024 |
| 10-q | Quarterly Reports | 63 | Aug 05, 2024 |
| 10-k/a | Quarterly Reports | 3 | Jul 26, 2024 |
| 8-k | 8K-related | 11 | Jul 24, 2024 |
| 10-k | Annual reports | 89 | May 31, 2024 |
| 8-k | 8K-related | 17 | May 13, 2024 |
| 8-k | 8K-related | 37 | May 01, 2024 |
| 8-k | 8K-related | 11 | Apr 23, 2024 |
| 10-q | Quarterly Reports | 65 | Feb 08, 2024 |